VistaGen Therapeutics, Inc. Soared

Mon, Aug 07, 2023 at 07:02 PM
VistaGen Therapeutics, Inc. Soared

VistaGen Therapeutics, Inc. (VTGN:NASDAQ) shot up at $13.05, representing a gain of 676.8%. On Mon, Aug 07, 2023, VTGN:NASDAQ touched a New 2-Week High of $13.05. The stock appeared on our News Catalysts scanner on Mon, Aug 07, 2023 at 03:06 PM in the 'BIOTECH' category. From Mon, Jul 24, 2023, the stock recorded 40.00% Up Days and 27.27% Green Days

The stock spiked on Mon, Aug 07, 2023 at $24.71 with a volume of 53M+.

About VistaGen Therapeutics, Inc. (VTGN:NASDAQ)

VistaGen Therapeutics Inc is a clinical-stage biopharmaceutical company that develops and commercializes product candidates for patients with central nervous system diseases. Its product AV-101 is currently being evaluated in a Phase 2 monotherapy study.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.